BMD
NAGE

Better Money Decisions’s Niagen Bioscience NAGE Stock Holding History

Better Money Decisions’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,744
Closed -$11K – 610
2021
Q3 		$11K Hold
1,744
– – 0.01% 387
2021
Q2 		$17K Hold
1,744
– – 0.02% 295
2021
Q1 		$16K Buy
+1,744
New +$13.8K 0.02% 260

Other funds holding NAGE

YRHAM
Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $227M AUM 300.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Better Money Decisions's NAGE Position: Q4 2021 in Review

Better Money Decisions sold out of Niagen Bioscience (NAGE) in Q4 2021, closing a stake of 1,744 shares — an estimated $11K sold.

Better Money Decisions first reported a position in NAGE in Q1 2021 and held it in 3 quarters. The position peaked at $17K in Q2 2021. 83 funds tracked by Wall St. Rank hold NAGE as of Q4 2021.

  • Better Money Decisions reported no remaining Niagen Bioscience position as of Q4 2021 after selling out during the quarter.
  • Better Money Decisions sold 1,744 Niagen Bioscience shares in Q4 2021, an estimated $11K.
  • Better Money Decisions first reported a position in Niagen Bioscience in Q1 2021 and held it in 3 quarters.
  • Better Money Decisions's Niagen Bioscience position peaked at $17K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2021.

Based on Better Money Decisions's 13F filing for Q4 2021, filed 14 Feb 2022.